Mark W. Begor - Oct 25, 2024 Form 4 Insider Report for EQUIFAX INC (EFX)

Role
CEO, Director
Signature
/s/Lisa Stockard as Attorney-in-Fact
Stock symbol
EFX
Transactions as of
Oct 25, 2024
Transactions value $
-$7,052,383
Form type
4
Date filed
10/29/2024, 04:09 PM
Previous filing
Oct 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EFX Common Stock Options Exercise $8.72M +58.3K +53.4% $149.53 167K Oct 25, 2024 Direct F1, F2
transaction EFX Common Stock Sale -$1.87M -6.9K -4.12% $271.68 161K Oct 25, 2024 Direct F1, F2, F3
transaction EFX Common Stock Sale -$2.1M -7.7K -4.8% $272.32 153K Oct 25, 2024 Direct F1, F2, F4
transaction EFX Common Stock Sale -$5.78M -21.4K -14.03% $269.49 131K Oct 25, 2024 Direct F1, F2, F5
transaction EFX Common Stock Sale -$6.02M -22.3K -16.93% $270.45 109K Oct 25, 2024 Direct F1, F2, F6
holding EFX Common Stock 43.4K Oct 25, 2024 2-Year 2023 GRAT
holding EFX Common Stock 20K Oct 25, 2024 2-year Feb 2024 GRAT
holding EFX Common Stock 24.1K Oct 25, 2024 2-yr Jul 2024 GRAT
holding EFX Common Stock 24.2K Oct 25, 2024 3-yr Jul 2024 GRAT
holding EFX Common Stock 12.3K Oct 25, 2024 4-Year 2021 GRAT

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EFX Stock Option/Right to Buy Options Exercise $0 -58.3K -100% $0.00 0 Oct 25, 2024 Common Stock 58.3K $149.53 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/6/2023.
F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.
F3 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $271.085 to $272.06, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F4 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $272.07 to $272.73, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F5 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $269.015 to $269.99, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F6 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $270.00 to $270.95, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.